<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT201201035144N3</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2013-06-25</date_registration>
      <primary_sponsor>Vice Chancellor for Research Ardabil University of Medical Sciences</primary_sponsor>
      <public_title>Consumption effects of conjugated linoleic acid (CLA) supplementation on oxidative stress  and matrix metaloproteinases following exercise in young healthy &#13;
 males</public_title>
      <acronym></acronym>
      <scientific_title>Consumption effects of conjugated linoleic acid (CLA) supplementation on oxidative stress and matrix metaloproteinases after exhaustive training in young healthy males men</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2013-02-18</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>30</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/5493</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Basic scienece.</study_design>
      <phase>2-3</phase>
      <hc_freetext>Healthy trained individuals.</hc_freetext>
      <i_freetext>Intervention 1: Given 5.6 gram/day CLA for14 days and once exhaustive exercise for intervention group. Intervention 2: Giving 5.6 gram oral Paraffin to control group for 14 days and once exhausting exercise.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan></results_IPD_plan>
      <results_IPD_description></results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Seyedyashar Alamolhoda</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Biochemistry Dept, Ardabil University of Medical Sciences, Ardabil University of Medical Sciences, Daneshgah Avenue, Ardabil, Iran.</address>
        <city>Ardabil</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>5155653466</zip>
        <telephone>+98 41 1657 8793</telephone>
        <email>sy.alam@arums.ac.ir</email>
        <affiliation>Ardabil University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Mohammad Mazani</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Biochemistry Dept, Faculty of Medicine, Ardabil University of Medical Sciences, Daneshgah Avenue, Ardabil, Iran</address>
        <city>Ardabil</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>5618953141</zip>
        <telephone>+98 45 1551 2788</telephone>
        <email>m.mazani@arums.ac.ir</email>
        <affiliation>Ardabil University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Inclusion criteria: Young healthy males with moderate physical activity in 18-30 years old.&#13;
Exclusion criteria: Individuals with certain diseases, smoking, alcoholism and other supplements, having certain dietary, professional training, sedentary and having 25&lt;BMI&lt;18.5 (body mass index)Kg/m2.</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>30 years</agemax>
      <gender>Male</gender>
      <exclusion_criteria></exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>Z02.5</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Examination for participation in sport</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Other</i_code>
      <i_code>Placebo</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Given 5.6 gram/day CLA for14 days and once exhaustive exercise for intervention group.</i_keyword>
      <i_keyword>Giving 5.6 gram oral Paraffin to control group for 14 days and once exhausting exercise</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Exhaustion time. Timepoint: At the end of once training. Method of measurement: The signs and symptoms related to the complete exhaustion.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Oral Paraffin. Timepoint: Two week. Method of measurement: Gram.</sec_outcome>
      <sec_outcome>Height. Timepoint: At the beginning of intervention. Method of measurement: Stadiometers.</sec_outcome>
      <sec_outcome>Weight. Timepoint: At the beginning of intervention. Method of measurement: Digital scales.</sec_outcome>
      <sec_outcome>Malondialdehyde. Timepoint: At the beginning of intervention, previous and after of exercise. Method of measurement: Spectrophotometry.</sec_outcome>
      <sec_outcome>Total antioxidant capacity. Timepoint: At the beginning of intervention, previous and after of exercise. Method of measurement: Spectrophotometry.</sec_outcome>
      <sec_outcome>Superoxide dismutase. Timepoint: At the beginning of intervention, previous and after of exercise. Method of measurement: Spectrophotometry.</sec_outcome>
      <sec_outcome>Glutathione peroxidase. Timepoint: At the beginning of intervention, previous and after of exercise. Method of measurement: Spectrophotometry.</sec_outcome>
      <sec_outcome>Ascorbic acid. Timepoint: At the beginning of intervention, previous and after of exercise. Method of measurement: Spectrophotometry.</sec_outcome>
      <sec_outcome>Catalase. Timepoint: At the beginning of intervention, previous and after of exercise. Method of measurement: Spectrophotometry.</sec_outcome>
      <sec_outcome>Matrix metalloproteinase-2. Timepoint: At the beginning of intervention, previous and after of exercise. Method of measurement: ELISA.</sec_outcome>
      <sec_outcome>Matrix metalloproteinase-9. Timepoint: At the beginning of intervention, previous and after of exercise. Method of measurement: ELISA.</sec_outcome>
      <sec_outcome>Interlukine-6. Timepoint: At the beginning of intervention, previous and after of exercise. Method of measurement: ELISA.</sec_outcome>
      <sec_outcome>Tumor Necrosis factor-alpha. Timepoint: At the beginning of intervention, previous and after of exercise. Method of measurement: ELISA.</sec_outcome>
      <sec_outcome>Hs-CRP. Timepoint: At the beginning of intervention, previous and after of exercise. Method of measurement: Immunoturbidimetry.</sec_outcome>
      <sec_outcome>Paraoxonase-1. Timepoint: At the beginning of intervention, previous and after of exercise. Method of measurement: Spectrophotometry.</sec_outcome>
      <sec_outcome>Fasting blood suger. Timepoint: At the beginning of intervention, previous and after of exercise. Method of measurement: Spectrophotometry.</sec_outcome>
      <sec_outcome>Arylesterase (ARE). Timepoint: At the beginning of intervention, previous and after of exercise. Method of measurement: Spectrophotometry.</sec_outcome>
      <sec_outcome>HDL-Cholesterol. Timepoint: At the beginning of intervention, previous and after of exercise. Method of measurement: Spectrophotometry.</sec_outcome>
      <sec_outcome>LDL-Cholesterol. Timepoint: At the beginning of intervention, previous and after of exercise. Method of measurement: Spectrophotometry.</sec_outcome>
      <sec_outcome>Triglyceride. Timepoint: At the beginning of intervention, previous and after of exercise. Method of measurement: Spectrophotometry.</sec_outcome>
      <sec_outcome>Urea. Timepoint: At the beginning of intervention, previous and after of exercise. Method of measurement: Spectrophotometry.</sec_outcome>
      <sec_outcome>Creatinine. Timepoint: At the beginning of intervention, previous and after of exercise. Method of measurement: Spectrophotometry.</sec_outcome>
      <sec_outcome>Uric acid. Timepoint: At the beginning of intervention, previous and after exercise. Method of measurement: Spectrophotometry.</sec_outcome>
      <sec_outcome>Bilirubin. Timepoint: At the beginning of intervention, previous and after of exercise. Method of measurement: Spectrophotometry.</sec_outcome>
      <sec_outcome>Calcium. Timepoint: At the beginning of intervention, previous and after exercise. Method of measurement: Spectrophotometry.</sec_outcome>
      <sec_outcome>Complete blood count, hemoglobin and hematocrit. Timepoint: At the beginning of intervention, previous and after exercise. Method of measurement: Cell counter.</sec_outcome>
      <sec_outcome>Copper. Timepoint: At the beginning of intervention, previous and after exercise. Method of measurement: Atomic absorptions spectrophotometry.</sec_outcome>
      <sec_outcome>Zinc. Timepoint: At the beginning of intervention, previous and after exercise. Method of measurement: atomic absorption spectrophotometry.</sec_outcome>
      <sec_outcome>Iron (Fe). Timepoint: At the beginning of intervention, previous and after exercise. Method of measurement: Spectrophotometry.</sec_outcome>
      <sec_outcome>Magnesium(Mg). Timepoint: At the beginning of intervention, previous and after exercise. Method of measurement: spectrophotometry.</sec_outcome>
      <sec_outcome>Ceruloplasmin(Cp). Timepoint: At the beginning of intervention, previous and after exercise. Method of measurement: Spectrophotometry.</sec_outcome>
      <sec_outcome>Phosphorus. Timepoint: At the beginning of intervention, previous and after of exercise. Method of measurement: Spectrophotometry.</sec_outcome>
      <sec_outcome>Leptin. Timepoint: At the beginning of intervention, previous and after of exercise. Method of measurement: ELISA.</sec_outcome>
      <sec_outcome>Total Cholesterol. Timepoint: At the beginning of intervention, previous and after of exercise. Method of measurement: Spectrophotometry.</sec_outcome>
      <sec_outcome>Total protein. Timepoint: At the beginning of intervention, previous and after of exercise. Method of measurement: Spectrophotometry.</sec_outcome>
      <sec_outcome>Creatine phosphokinase(CK). Timepoint: At the beginning of intervention, previous and after of exercise. Method of measurement: Spectrophotometry.</sec_outcome>
      <sec_outcome>Parathormone(PTH). Timepoint: At the beginning of intervention, previous and after exercise. Method of measurement: ELISA.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Vice Chancellor for Research Ardabil University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2013-02-18</approval_date>
        <contact_name>Ethic Committee of Ardabil University of Medical Sciences</contact_name>
        <contact_address>Ethic Committee of Ardabil University of Medical Sciences, Vice Chancellor for Research, Ardabil University of Medical Sciences, Ardabil University of Medical Sciences, Daneshgah Avenue, Ardabil, Iran Ardabil  Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
